The global demand for Mexoryl SX (Ecamsule) Market is presumed to reach the market size of nearly USD 148.61 MN by 2028 from USD 51.61 MN in 2021 with a CAGR of 6.51% under the study period 2022 - 2028.
Ecamsule, which is also known as terephthalylidene dicamphor sulfonic acid, is marketed under the trade name Mexoryl SX. It primarily shields against UVA radiation, the primary cause of skin cancer and premature skin aging. In addition, Mexoryl SX works as a photostable drug & medication that inhibit UV-induced pyrimidine dimer formation and postpones the onset of skin cancer.
The usage of mexoryl SX-based sunscreens has increased due to rising concerns about skin protection from the sun's detrimental rays and increased awareness of skin cancer, which bolster the mexoryl SX market. Furthermore, Mexoryl SX (ecamsule) is used in the creation & development of anti-skin cancer medications due to the rise in the spread of melanoma and non-melanoma skin cancers. Therefore, it is estimated that this will flourish demand for the mexoryl (SX) market. In addition, the global mexoryl SX (ecamsule) market will rise in response to growing consumer awareness of skincare and beauty products, rising living standards, and widespread use of photo-protection products for all skin types. Furthermore, the mexoryl SX (ecamsule) market will drive by a surge in R&D activities for developing a broad range of sunscreen formulations and increasing demand for sunscreens, anti-aging creams, and other cosmetic items based on mexoryl SX (ecamsule).
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mexoryl sx (ecamsule). The growth and trends of mexoryl sx (ecamsule) industry provide a holistic approach to this study.
This section of the mexoryl sx (ecamsule) market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Purity Level
- Less Than 98%
- More Than 98%
This section covers the regional outlook, which accentuates current and future demand for the Mexoryl SX (Ecamsule) market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Mexoryl SX (Ecamsule) Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mexoryl sx (ecamsule) market include L'Oréal S.A., Skylead Pharmaceuticals & Chemicals, ChemScene LLC, Biosynth Carbosynth, NATIONAL Analytical Corporation, Norna Technology Co., Derma Companies, MFCI CO. LTD, Merck KGaA, Parchem Fine and Specialty Chemicals. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.